000			04264nam a22005297a 4500
001			sulb-eb0023007
003			BD-SySUS
005			20160413122331.0
007			cr nn 008mamaa
008			120811s2013 xxu| s |||| 0|eng d
020			_a9781607612599 _9978-1-60761-259-9
024	7		_a10.1007/978-1-60761-259-9 _2doi
050		4	_aRC870-923.2
050		4	_aRC875-899.5
072		7	_aMJS _2bicssc
072		7	_aMED088000 _2bisacsh
082	0	4	_a616.6 _223
245	1	0	_aManagement of Prostate Cancer _h[electronic resource] / _cedited by Eric A. Klein, J. Stephen Jones.
250			_a3rd ed. 2013.
264		1	_aTotowa, NJ : _bHumana Press : _bImprint: Humana Press, _c2013.
300			_aXII, 428 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aCurrent Clinical Urology
505	0		_aEpidemiology and Risk Factors -- Twenty years and counting: is PSA still useful in 2010? -- Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications -- Beyond PSA: Promising New Markers for Prostate Cancer -- Hereditary Prostate Cancer and Genetic Risk -- Prostate Inflammation and Prostate Cancer -- Molecular Progression of Prostate Cancer: Androgens and Estrogens -- The Role of Obesity and Diet in Prostate Cancer -- Prostate Cancer Risk Reduction by Chemoprevention -- Current Issues in Pathologic Evaluation -- Optimum Prostate Biopsy: Technique and Strategies -- The Utility of Nomograms in Routine Clinical Practice -- Active Surveillance Comes of Age -- Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer -- Contemporary External Beam Radiotherapy -- Surgery, Brachytherapy, or  External Beam Radiation for Low and Intermediate-Risk Disease? -- The Role for Radical Prostatectomy in Advanced Prostate Cancer -- Radiation Therapy in the Management of Locally Advanced Prostate Cancer -- Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer -- Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current  Therapy Options -- Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer -- Management of Newly Diagnosed Metastatic Disease -- Pitfalls of Androgen Deprivation Therapy -- Current Management of Castration-resistant Prostate Cancer (CRPC) -- Radiopharmaceuticals and Bone Metastasis.
520			_aThe thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer.  Highlighting the latest major advances in the field, the book includes chapters on the most controversial areas of prostate cancer – screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease. With its comprehensive illustrations and contributions from renowned experts in the field, Management of Prostate Cancer, 3rd Edition is an invaluable resource for practitioners in the treatment of prostate cancer.
650		0	_aMedicine.
650		0	_aOncology.
650		0	_aSurgery.
650		0	_aUrology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aUrology.
650	2	4	_aOncology.
650	2	4	_aSurgery.
700	1		_aKlein, Eric A. _eeditor.
700	1		_aJones, J. Stephen. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781607612582
830		0	_aCurrent Clinical Urology
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-60761-259-9
912			_aZDB-2-SME
942			_2Dewey Decimal Classification _ceBooks
999			_c45099 _d45099